Erythropoietin News and Research

RSS
Erythropoietin, or its alternative erythropoetin or EPO, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow.
Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Emerging strategies to boost healthy RBCs may reduce burden of anemia linked to blood disorders

Research performed in anemic mice shows acetate stimulates the formation of red blood cells

Research performed in anemic mice shows acetate stimulates the formation of red blood cells

EPO administered to preterm infants linked with reduced risk of brain injury

EPO administered to preterm infants linked with reduced risk of brain injury

Study explores neurological outcomes in patients treated for traumatic brain injury

Study explores neurological outcomes in patients treated for traumatic brain injury

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Acceleron, Celgene to give oral presentations on beta-thalassemia, myelodysplastic syndromes at EHA meeting

Study: Mutations could have major impact on treatment of human blood diseases

Study: Mutations could have major impact on treatment of human blood diseases

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

Akebia completes enrollment in ongoing 200-patient Phase 2b study of AKB-6548

Erythropoietin may promote cancer cell proliferation and survival

Erythropoietin may promote cancer cell proliferation and survival

Study shows beneficial effects of normobaric oxygen on cerebral ischemic injury

Study shows beneficial effects of normobaric oxygen on cerebral ischemic injury

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

AstraZeneca, FibroGen partner to develop, commercialize anemia drug candidate FG-4592

New data on PROLOR Biotech's hGH-CTP and MOD-6030 to be presented at ENDO 2013

New data on PROLOR Biotech's hGH-CTP and MOD-6030 to be presented at ENDO 2013

Whitehead Institute researchers identify drug target for anemia

Whitehead Institute researchers identify drug target for anemia

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

PROLOR Biotech announces initiation of hGH-CTP Phase III trial in growth hormone deficient adults

TSRI scientists devise new technique to find therapeutic antibodies

TSRI scientists devise new technique to find therapeutic antibodies

Prior administration of erythropoietin reduces need for blood transfusions

Prior administration of erythropoietin reduces need for blood transfusions

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Two studies shed light on molecular biology of three blood disorders

Two studies shed light on molecular biology of three blood disorders

Aarbepoetin alfa does not improve anemic heart failure patients' health

Aarbepoetin alfa does not improve anemic heart failure patients' health